Tesla reported a 43% decline in third-quarter net income to $787 million, down from $1.37 billion a year earlier, while revenue remained flat at $28.05 billion. The drop in profitability coincided with a significant increase in spending on new ventures: research and development costs rose 69% to $2.76 billion, and capital expenditures more than doubled to $4.73 billion. Operating profit fell 56% to $718 million as the company delivered approximately 2% fewer vehicles.
The increased spending is directed toward two primary initiatives: the Optimus humanoid robot and the Cybercab driverless taxi. Tesla confirmed that production of Optimus has begun at its Fremont, California factory, describing the units as "production-quality." CEO Elon Musk stated that reaching a target of 20,000 robots per week will take at least a year due to ongoing design changes, particularly regarding the robot's hand and durability. External deliveries are projected for late 2027.
Regarding the Cybercab, Tesla aims to deliver vehicles to customers by the end of 2026, although all units produced so far are designated for Tesla’s internal robotaxi fleet. The company has not announced a final price, though it previously cited a target under $30,000. This push occurs amid an open federal safety audit, with Tesla’s sworn responses to regulators due October 30. Additionally, boards of Tesla and SpaceX have formed special committees to study a potential combination, requiring support from holders of 50% of outstanding Tesla shares.
Tesla’s financial results illustrate the high cost of pivoting from a pure automotive manufacturer to a robotics and AI-driven mobility provider. The sharp decline in operating profit, driven by doubled capital expenditures and rising R&D, signals that the company is absorbing substantial losses to scale unproven products like Optimus and the Cybercab. While revenue stability suggests core demand remains intact, the margin compression highlights the tension between maintaining current operations and funding speculative future growth. Investors must weigh whether this aggressive spending yields tangible returns before cash reserves are depleted or market confidence erodes further.
Regulatory and execution risks loom large over these new ventures. The Cybercab’s timeline faces scrutiny due to an ongoing federal safety audit, creating uncertainty around consumer delivery dates despite management’s optimistic targets. Similarly, Optimus production delays indicate technical hurdles remain unresolved, challenging previous timelines. The potential merger discussions with SpaceX add another layer of complexity, requiring significant shareholder approval. These factors suggest that Tesla’s path to profitability in these new segments is fraught with operational and regulatory obstacles that could impact near-term financial performance.
